Publication: Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity
dc.contributor.author | Osés Recalde, Maddi | |
dc.contributor.author | Cadenas-Sánchez, Cristina | |
dc.contributor.author | Medrano Echeverría, María | |
dc.contributor.author | Galbete Jiménez, Arkaitz | |
dc.contributor.author | Miranda Ferrúa, Emiliano | |
dc.contributor.author | Ruiz, Jonatan R. | |
dc.contributor.author | Sánchez-Valverde, Felix | |
dc.contributor.author | Ortega, Francisco B. | |
dc.contributor.author | Cabeza Laguna, Rafael | |
dc.contributor.author | Villanueva Larre, Arantxa | |
dc.contributor.author | Idoate, Fernando | |
dc.contributor.author | Labayen Goñi, Idoia | |
dc.contributor.department | Osasun Zientziak | eu |
dc.contributor.department | Institute of Smart Cities - ISC | en |
dc.contributor.department | Institute on Innovation and Sustainable Development in Food Chain - ISFOOD | en |
dc.contributor.department | Ciencias de la Salud | es_ES |
dc.contributor.funder | Gobierno de Navarra / Nafarroako Gobernua | es |
dc.date.accessioned | 2022-08-19T09:22:04Z | |
dc.date.available | 2022-08-19T09:22:04Z | |
dc.date.issued | 2022 | |
dc.date.updated | 2022-08-19T09:14:00Z | |
dc.description.abstract | Background: the early detection and management of children with metabolic associ-ated fatty liver disease (MAFLD) is challenging. Objective: to develop a non-invasive and accurate prediction protocol for the identi-fication of MAFLD among children with overweight/obesity candidates to confirma-tory diagnosis. Methods: a total of 115 children aged 8–12 years with overweight/obesity, rec-ruited at a primary care, were enrolled in this cross-sectional study. The external vali-dation was performed using a cohort of children with overweight/obesity (N=46)aged 8.5–14.0 years. MAFLD (≥5.5% hepatic fat) was diagnosed by magnetic reso-nance imaging (MRI). Fasting blood biochemical parameters were measured, and25 candidates’ single nucleotide polymorphisms (SNPs) were determined. Variablespotentially associated with the presence of MAFLD were included in a multivariatelogistic regression. Results: children with MAFLD (36%) showed higher plasma triglycerides (TG),insulin, homeostasis model assessment ofinsulin resistance (HOMA-IR), alanineaminotransferase (ALT), aspartate transaminase (AST), glutamyl-transferase (GGT)and ferritin (p< 0.05). The distribution of the risk-alleles of PPARGrs13081389, PPARGrs1801282, HFErs1800562 and PNLPLA3rs4823173 was significantly different between children with and without MAFLD (p<0.05). Threebiochemical- and/or SNPs-based predictive models were developed, showingstrong discriminatory capacity (AUC-ROC: 0.708–0.888) but limited diagnosticperformance (sensitivity 67%–82% and specificity 63%–69%). A prediction proto-col with elevated sensitivity (72%) and specificity (84%) based on two consecutive steps was developed. The external validation showed similar results: sensitivity of 70% and specificity of 85%. Conclusions: the HEPAKID prediction protocol is an accurate, easy to implant, minimally invasive and low economic cost tool useful for the early identification and management of paediatric MAFLD in primary care. | en |
dc.description.sponsorship | Economic Development of Goverment of Navarra, Grant/Award Numbers: 0011-1365-2019-000000, 0011-1365-2020-00140; Fondos Estructurales de la Unión Europea (FEDER); Instituto de Salud Carlos III, Grant/Award Number: PI13/01335; Ministerio de Economía, Industria y Competitividad, Gobierno de España, Grant/Award Number: DEP2016-78377-R; Secretaría de Estado de Investigación, Desarrollo e Innovación, Grant/Award Number: BES-2017-080770 | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Oses, M.; Cadenas-Sanchez, C.; Medrano, M.; Galbete, A.; Miranda-Ferrua, E.; Ruiz, J. R.; Sánchez-Valverde, F.; Ortega, F. B.; Cabeza, R.; Villanueva, A.; Idoate, F.; Labayen, I.. (2022). Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity. Pediatric Obesity. 17. | en |
dc.identifier.doi | 10.1111/ijpo.12917 | |
dc.identifier.issn | 2047-6302 | |
dc.identifier.uri | https://academica-e.unavarra.es/handle/2454/43819 | |
dc.language.iso | eng | en |
dc.publisher | Wiley | en |
dc.relation.ispartof | Pediatric Obesity, 2022, 17 | en |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PI13%2F01335/ES/ | en |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/1PE/DEP2016-78377-R | en |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/BES-2017-080770 | en |
dc.relation.publisherversion | https://doi.org/10.1111/ijpo.12917 | |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License | en |
dc.rights.accessRights | Acceso abierto / Sarbide irekia | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | Fatty liver | en |
dc.subject | Metabolic diseases | en |
dc.subject | Paediatric obesity | en |
dc.subject | Primary health care | en |
dc.title | Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity | en |
dc.type | Artículo / Artikulua | es |
dc.type | info:eu-repo/semantics/article | en |
dc.type.version | Versión publicada / Argitaratu den bertsioa | es |
dc.type.version | info:eu-repo/semantics/publishedVersion | en |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | a3f4aa23-172a-47fb-9faf-647f655f7085 | |
relation.isAuthorOfPublication | eeecebce-3369-4e9a-8372-894379eeaa96 | |
relation.isAuthorOfPublication | 304856ca-cc85-4094-8ca3-b17f4c5f33de | |
relation.isAuthorOfPublication | 4bb570ab-10a2-4b9a-8ee8-893bbd090df6 | |
relation.isAuthorOfPublication | 42fe20f8-5341-4c0e-8686-333ce816adfd | |
relation.isAuthorOfPublication | d3bfd5bf-8426-455b-bcc4-897ddb0d4c2e | |
relation.isAuthorOfPublication | b36e2b1d-3088-4089-806e-fd3040e9583a | |
relation.isAuthorOfPublication.latestForDiscovery | a3f4aa23-172a-47fb-9faf-647f655f7085 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Oses_DevelopmentPrediction_1660891594603_41623.pdf
- Size:
- 1.23 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.78 KB
- Format:
- Item-specific license agreed to upon submission
- Description: